Yazar "Bozer, BM" seçeneğine göre listele

Listeleniyor 1 - 1 / 1
  • [ X ]
    Öğe
    Poly(CnO) and Poly(CcO) Organo-Particles Produced from Coconut Oil (CnO) and Cocoa Oil (CcO): Synthesis, Characterization, Bio and Anticancer Activity
    (HORIZON RESEARCH PUBLISHING, 2025) Alpaslan, D; Dudu, TE; Bozer, BM; Aktaş, N; Türk, M
    With the increasing number of cancer cases in recent years, the solution methods suggested for these cases are also of great importance. Within the scope of the presented study, we aimed to develop an alternative material in cancer immunotherapy by synthesizing poly(coconut oil) (p(CnO)) and poly(cacao oil) (p(CcO)) organo-particles from coconut and cocoa oils. The structural features of these particles synthesized using the redox polymerization technique were elucidated by various characterization methods. The chemical structure and functional groups of p(CnO) and p(CcO) organo-particles were determined by Fourier Transform Infrared Spectroscopy (FT-IR). Organo particle size and zeta potential values were determined by the dynamic light scattering (DLS) method using Zetasizer device. The morphological features of the particles were determined by Scanning Electron Microscopy (SEM). Bioactivity properties were determined by antioxidant, antimicrobial and biocompatibility analyses. In this study, the effects of p(CnO) and p(CcO) organo-particles on cytotoxicity and apoptotic processes against L-929 fibroblast and Capan-1 pancreatic cancer cell lines were also investigated. p(CnO) and p(CcO) organo-particles Capan-1 cell lines were determined to have significant cytotoxic activity at all doses studied. An increase in cell number was observed in L-929 fibroblast cells treated with p(CnO) and p(CcO) organo-particles. As a result, findings have been obtained that the p(CcO) organo particle triggers the apoptotic mechanism. On Capan-1 pancreatic cancer cells, p(CcO) was found to have a fatal impact akin to that of doxorubicin. It is anticipated that combining p(CcO) with doxorubicin could potentially lead to better outcomes than using doxorubicin alone.